The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to compare the 3 years DFS of dose-dense epirubicin and
cyclophosphamide followed by paclitaxel with paclitaxel plus carboplatin as adjuvant therapy
for triple-negative breast cancer.
The other purpose of this trial is to observe the patient's tolerance.